IRVINE, Calif., Jan. 2, 2018 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in
patient-focused innovations for structural heart disease and
critical care monitoring, is scheduled to present at the J.P.
Morgan Healthcare Conference at the Westin St. Francis in
San Francisco on Monday, January 8, 2018.
Michael A. Mussallem, chairman and chief executive
officer, is scheduled to speak to conference attendees at
8:00 a.m. PT. A live webcast of
the presentation will be available to all interested parties on the
Edwards Lifesciences investor relations website at
http://ir.edwards.com/events.cfm. An archived version of the
webcast will be available later that day on the Edwards investor
relations website in the News and Events section and via the
Edwards Lifesciences Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences, based
in Irvine, Calif., is the global
leader in patient-focused medical innovations for structural heart
disease, as well as critical care and surgical monitoring.
Driven by a passion to help patients, the company collaborates with
the world's leading clinicians and researchers to address unmet
healthcare needs, working to improve patient outcomes and enhance
lives. For more information, visit www.Edwards.com and follow us on
Twitter at @EdwardsLifeSci.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
View original content with
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300574190.html
SOURCE Edwards Lifesciences Corporation